4-(2-fluoro-4-methoxyphenyl)-7-[[4-(1,1,1,2-tetrafluorobutan-2-yl)imidazol-1-yl]methyl]quinoline-2-carboxamide
C25H21F5N4O2 — CID 121391537
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(2-fluoro-4-methoxyphenyl)-7-[[4-(1,1,1,2-tetrafluorobutan-2-yl)imidazol-1-yl]methyl]quinoline-2-carboxamide
4-(2-fluoro-4-methoxyphenyl)-7-[[4-(1,1,1,2-tetrafluorobutan-2-yl)imidazol-1-yl]methyl]quinoline-2-carboxamide (PubChem CID 121391537) has the molecular formula C25H21F5N4O2 and a molecular weight of 504.46 g/mol. Its IUPAC name is 4-(2-fluoro-4-methoxyphenyl)-7-[[4-(1,1,1,2-tetrafluorobutan-2-yl)imidazol-1-yl]methyl]quinoline-2-carboxamide.
Molecular Properties
| Compound Name | 4-(2-fluoro-4-methoxyphenyl)-7-[[4-(1,1,1,2-tetrafluorobutan-2-yl)imidazol-1-yl]methyl]quinoline-2-carboxamide |
|---|---|
| PubChem CID | 121391537 |
| Molecular Formula | C25H21F5N4O2 |
| Molecular Weight | 504.46 g/mol |
| Exact Mass | 504.16 |
| IUPAC Name | 4-(2-fluoro-4-methoxyphenyl)-7-[[4-(1,1,1,2-tetrafluorobutan-2-yl)imidazol-1-yl]methyl]quinoline-2-carboxamide |
| SMILES | CCC(F)(c1cn(Cc2ccc3c(-c4ccc(OC)cc4F)cc(C(N)=O)nc3c2)cn1)C(F)(F)F |
| InChI | InChI=1S/C25H21F5N4O2/c1-3-24(27,25(28,29)30)22-12-34(13-32-22)11-14-4-6-17-18(10-21(23(31)35)33-20(17)8-14)16-7-5-15(36-2)9-19(16)26/h4-10,12-13H,3,11H2,1-2H3,(H2,31,35) |
| InChIKey | NGHTZBXDPRRARW-UHFFFAOYSA-N |
| XLogP | 5.53 |
| TPSA | 83.03 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 504.46 |
| LogP ≤ 5 | 5.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121391537 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.